Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiarelli, F.
Right arrow Articles by Mezzetti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiarelli, F.
Right arrow Articles by Mezzetti, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 49, Issue 7 1258-1263, Copyright © 2000 by American Diabetes Association


ARTICLES

Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration

F Chiarelli, F Cipollone, F Romano, S Tumini, F Costantini, L di Ricco, M Pomilio, SD Pierdomenico, M Marini, F Cuccurullo and A Mezzetti
Centro per lo Studio dell'Ipertensione Arteriosa delle Dislipidemie e dell'Aterosclerosi, Department of Biomedical Sciences, University G.D'Annunzio School of Medicine, Chieti, Italy.

Hyperglycemia has been causally linked to vascular and glomerular dysfunction by a variety of biochemical mechanisms, including a glucose-dependent abnormality in nitric oxide (NO) production and action. NO is a candidate for mediating hyperfiltration and the increased vascular permeability induced by diabetes. Serum nitrite and nitrate (NO2-+ NO3-) concentrations were assessed as an index of NO production in 30 adolescents and young adults with type 1 diabetes, 15 with and 15 without microalbuminuria (albumin excretion rate [AER] between 20 and 200 microg/min), compared with a well-balanced group of healthy control subjects. In all subjects, glomerular filtration rate (GFR) was determined by radionuclide imaging. Our study showed that NO2- + NO3- serum content and GFR values were significantly higher in microalbuminuric diabetic patients than in the other 2 groups. GFR was significantly and positively related to AER levels (r2 = 0.75, P < 0.0001), whereas NO2- + NO3- serum content was independently associated with both AER and GFR values (beta = 2.086, P = 0.05, beta = 1.273, P = 0.0085, respectively), suggesting a strong link between circulating NO, glomerular hyperfiltration, and microalbuminuria in young type 1 diabetic patients with early nephropathy. Interestingly, mean HbA1c, serum concentration was significantly higher in microalbuminuric than in normoalbuminuric diabetic subjects (P < 0.05) and was independently associated with AER values, suggesting a role for chronic hyperglycemia in the genesis of diabetic nephropathy. Moreover, HbA1c serum concentration was significantly and positively related to NO2 + NO3 serum content (r2 = 0.45, P = 0.0063) and GFR values (r2 = 0.57, P = 0.0011), suggesting that chronic hyperglycemia may act through a mechanism that involves increased NO generation and/or action. In conclusion, we suggest that in young type 1 diabetic patients with early nephropathy, chronic hyperglycemia is associated with an increased NO biosynthesis and action that contributes to generating glomerular hyperfiltration and persistent microalbuminuria.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
D. Z.I. Cherney, J. A. Miller, J. W. Scholey, T. J. Bradley, C. Slorach, J. R. Curtis, M. G. Dekker, R. Nasrallah, R. L. Hebert, and E. B. Sochett
The Effect of Cyclooxygenase-2 Inhibition on Renal Hemodynamic Function in Humans With Type 1 Diabetes
Diabetes, March 1, 2008; 57(3): 688 - 695.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
U. Skaleric, B. Gaspirc, N. McCartney-Francis, A. Masera, and S. M. Wahl
Proinflammatory and Antimicrobial Nitric Oxide in Gingival Fluid of Diabetic Patients with Periodontal Disease
Infect. Immun., December 1, 2006; 74(12): 7010 - 7013.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Savino, P. Pelliccia, C. Schiavone, A. Primavera, S. Tumini, A. Mohn, and F. Chiarelli
Serum and Urinary Nitrites and Nitrates and Doppler Sonography in Children With Diabetes
Diabetes Care, December 1, 2006; 29(12): 2676 - 2681.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
B. Y. Salazar-Vazquez, M. Intaglietta, M. Rodriguez-Moran, and F. Guerrero-Romero
Blood Pressure and Hematocrit in Diabetes and the Role of Endothelial Responses in the Variability of Blood Viscosity
Diabetes Care, July 1, 2006; 29(7): 1523 - 1528.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. B. Sochett, D. Z.I. Cherney, J. R. Curtis, M. G. Dekker, J. W. Scholey, and J. A. Miller
Impact of Renin Angiotensin System Modulation on the Hyperfiltration State in Type 1 Diabetes
J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1703 - 1709.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
I. Londono and M. Bendayan
Glomerular handling of native albumin in the presence of circulating modified albumins by the normal rat kidney
Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1201 - F1209.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
F. Chiarelli, D. Di Marzio, F. Santilli, A. Mohn, A. Blasetti, F. Cipollone, A. Mezzetti, and A. Verrotti
Effects of Irbesartan on Intracellular Antioxidant Enzyme Expression and Activity in Adolescents and Young Adults With Early Diabetic Angiopathy
Diabetes Care, July 1, 2005; 28(7): 1690 - 1697.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. Pistrosch, K. Herbrig, B. Kindel, J. Passauer, S. Fischer, and P. Gross
Rosiglitazone Improves Glomerular Hyperfiltration, Renal Endothelial Dysfunction, and Microalbuminuria of Incipient Diabetic Nephropathy in Patients
Diabetes, July 1, 2005; 54(7): 2206 - 2211.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg
From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines
Endocr. Rev., December 1, 2004; 25(6): 971 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. D. A. Stehouwer
Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease
Nephrol. Dial. Transplant., April 1, 2004; 19(4): 778 - 781.
[Full Text] [PDF]


Home page
Diabetes CareHome page
F. De Cobelli, P. Fiorina, G. Perseghin, M. Magnone, M. Venturini, G. Zerbini, A. Zanello, G. Mazzolari, L. Monti, V. Di Carlo, et al.
L-Arginine-Induced Vasodilation of the Renal Vasculature Is Preserved in Uremic Type 1 Diabetic Patients After Kidney and Pancreas but not After Kidney-Alone Transplantation
Diabetes Care, April 1, 2004; 27(4): 947 - 954.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. W. Brands, T. D. Bell, and B. Gibson
Nitric Oxide May Prevent Hypertension Early in Diabetes by Counteracting Renal Actions of Superoxide
Hypertension, January 1, 2004; 43(1): 57 - 63.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. Delles, M. P. Schneider, S. Oehmer, E. H. Fleischmann, and R. E. Schmieder
L-Arginine-Induced Vasodilation of the Renal Vasculature Is Not Altered in Hypertensive Patients With Type 2 Diabetes
Diabetes Care, June 1, 2003; 26(6): 1836 - 1840.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. D. Hoeldtke, K. D. Bryner, D. R. McNeill, S. S. Warehime, K. Van Dyke, and G. Hobbs
Oxidative Stress and Insulin Requirements in Patients with Recent-Onset Type 1 Diabetes
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1624 - 1628.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. D. Hoeldtke, K. D. Bryner, D. R. McNeill, G. R. Hobbs, J. E. Riggs, S. S. Warehime, I. Christie, G. Ganser, and K. Van Dyke
Nitrosative Stress, Uric Acid, and Peripheral Nerve Function in Early Type 1 Diabetes
Diabetes, September 1, 2002; 51(9): 2817 - 2825.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.